1. Home
  2. ALG vs MESO Comparison

ALG vs MESO Comparison

Compare ALG & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alamo Group Inc.

ALG

Alamo Group Inc.

HOLD

Current Price

$161.05

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo Mesoblast Limited

MESO

Mesoblast Limited

HOLD

Current Price

$15.50

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALG
MESO
Founded
1955
2004
Country
United States
Australia
Employees
N/A
81
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
ALG
MESO
Price
$161.05
$15.50
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$225.00
N/A
AVG Volume (30 Days)
151.2K
123.6K
Earning Date
05-04-2026
02-26-2026
Dividend Yield
0.81%
N/A
EPS Growth
N/A
N/A
EPS
2.41
N/A
Revenue
$1,603,715,000.00
N/A
Revenue This Year
$5.26
$629.74
Revenue Next Year
$3.97
$30.65
P/E Ratio
$66.95
N/A
Revenue Growth
N/A
N/A
52 Week Low
$145.76
$10.17
52 Week High
$233.29
$21.50

Technical Indicators

Market Signals
Indicator
ALG
MESO
Relative Strength Index (RSI) 59.17 59.17
Support Level $158.84 $13.71
Resistance Level $181.19 $16.11
Average True Range (ATR) 4.49 0.49
MACD 1.68 0.09
Stochastic Oscillator 86.48 84.89

Price Performance

Historical Comparison
ALG
MESO

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial, and agricultural use. Its products include agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck-mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, snow removal equipment, etc. The company's reportable segments are Vegetation Management, which generates the maximum revenue, and Industrial Equipment. Geographically, the company generates maximum revenue from the United States, followed by Canada, France, the UK, Brazil, the Netherlands, and other regions.

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.

Share on Social Networks: